Home > Riviste > Italian Journal of Dermatology and Venereology > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6) > Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6):800-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW  PDT FOR NON-MELANOMA SKIN CANCER Free accessfree

Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6):800-5

DOI: 10.23736/S0392-0488.18.05998-9

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Long-term efficacy data for daylight-PDT

Carlota GUTIÉRREZ GARCÍA-RODRIGO, Cristina PELLEGRINI, Antonella PICCIONI, Matteo MAINI, Maria Concetta FARGNOLI

Department of Dermatology, University of L’Aquila, L’Aquila, Italy



INTRODUCTION: Conventional photodynamic therapy (c-PDT) is an established successful treatment for non-melanoma skin cancers (NMSC). Daylight PDT (DL-PDT) was introduced to overcome the main inconveniencies associated with c-PDT such as pain during illumination and long clinic visits. DL-PDT was shown to have similar short-term efficacy to c-PDT for the treatment of mild/moderate actinic keratosis (AKs) but it is associated with better tolerability. Since AKs tend to regress and reoccur over time, data on long-term efficacy of DL-PDT become crucial.
EVIDENCE ACQUISITION: We performed a systematic review search up to February 2018 of available studies on DL-PDT long-term efficacy using the MEDLINE database and made a manual search of selected references.
EVIDENCE SYNTHESIS: Most current studies on DL-PDT have limited follow-up periods of 3 to 6 months. Only 2 randomized, intra-individual studies provided efficacy data on AK treatment at 12 month-follow-up and supported the long-term efficacy of this novel treatment modality showing a low recurrence rate, varying from 8.7% to 13%. Current evidences for other NMSCs are limited and efficacy seems to be not as good as for AK.
CONCLUSIONS: DL-PDT is a very promising treatment for mild to moderate AKs of the face and scalp. Efficacy outcomes of DL-PDT are similar to those of c-PDT in the short-term. Additional studies are required to increase our knowledge on DL-PDT long-term efficacy, as limited data are currently available.


KEY WORDS: Photochemotherapy - Treatment outcome - Keratosis, actinic

inizio pagina